Literature DB >> 33338745

The role of miRNAs in colorectal cancer progression and chemoradiotherapy.

Ning Zhang1, Xianyu Hu1, Yinan Du2, Juan Du3.   

Abstract

Colorectal cancer (CRC) is known as the third most common cancer as well as the fourth most deadly cancer worldwide. CRC accounts for approximately 10 % of all new cancer cases globally, remaining the second most frequent cause of cancer-related deaths. MicroRNAs (miRNAs) are a class of small noncoding RNAs that can affect a variety of cellular and molecular targets. Depending on the cell environment in which the information is expressed, miRNAs can serve as a CRC suppressor or promoter and play essential roles in several biological processes. In this review, we summarized the relationship between miRNAs and proliferation, metastasis, angiogenesis, autophagy, apoptosis, and the chemoradiotherapy of CRC, revealing that relevant miRNAs could serve as potential targets for CRC therapy.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Biomarkers; Cancer therapy; Chemoradiotherapy; Colorectal cancer; microRNA

Mesh:

Substances:

Year:  2020        PMID: 33338745     DOI: 10.1016/j.biopha.2020.111099

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  16 in total

Review 1.  Diagnostic and therapeutic biomarkers in colorectal cancer: a review.

Authors:  Jéssica Vieira de Assis; Lucélia Antunes Coutinho; Ifeoluwa Temitayo Oyeyemi; Oyetunde Timothy Oyeyemi; Rafaella Fortini E Queiroz Grenfell
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

2.  Over-expression of miR-193a-3p regulates the apoptosis of colorectal cancer cells by targeting PAK3.

Authors:  Tao Ma; Hai Li; Wenjing Yang; Quanxia Liu; Hui Yan
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

3.  Comprehensive analysis of ceRNA network of ERCC4 in colorectal cancer.

Authors:  Huixin Hu; Songyi Liu; Aining Chu; Jing Chen; Chengzhong Xing; Jingjing Jing
Journal:  PeerJ       Date:  2021-12-14       Impact factor: 2.984

Review 4.  Roles and mechanisms of exosomal non-coding RNAs in human health and diseases.

Authors:  Chen Li; Yu-Qing Ni; Hui Xu; Qun-Yan Xiang; Yan Zhao; Jun-Kun Zhan; Jie-Yu He; Shuang Li; You-Shuo Liu
Journal:  Signal Transduct Target Ther       Date:  2021-11-10

Review 5.  miRNAs in Cancer (Review of Literature).

Authors:  Beata Smolarz; Adam Durczyński; Hanna Romanowicz; Krzysztof Szyłło; Piotr Hogendorf
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

Review 6.  The Emerging Roles of Circular RNAs in the Chemoresistance of Gastrointestinal Cancer.

Authors:  Man Wang; Fei Yu; Yuan Zhang; Lei Zhang; Wenguang Chang; Kun Wang
Journal:  Front Cell Dev Biol       Date:  2022-01-21

Review 7.  A review on interplay between small RNAs and oxidative stress in cancer progression.

Authors:  Aparimita Das; Harsha Ganesan; Sushmitha Sriramulu; Francesco Marotta; N R Rajesh Kanna; Antara Banerjee; Fang He; Asim K Duttaroy; Surajit Pathak
Journal:  Mol Cell Biochem       Date:  2021-07-22       Impact factor: 3.396

8.  MicroRNA-934 facilitates cell proliferation, migration, invasion and angiogenesis in colorectal cancer by targeting B-cell translocation gene 2.

Authors:  Bo Li; Xianyi Liu; Guogang Wu; Jiawen Liu; Shouliang Cai; Fuxin Wang; Chunyu Yang; Jisheng Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  LncRNA GAS5 Interacts with MicroRNA-10b to Inhibit Cell Proliferation and Migration and Induces Apoptosis in Colorectal Cancer.

Authors:  Rui-Qi Yang; Zhe-Zhu Jin; San-Ya Jiang; Yong-Jun Jin
Journal:  Comput Math Methods Med       Date:  2022-01-22       Impact factor: 2.238

10.  Specificity protein 1-induced serine peptidase inhibitor, Kunitz Type 1 antisense RNA1 regulates colorectal cancer cell proliferation, migration, invasion and apoptosis through targeting heparin binding growth factor via sponging microRNA-214.

Authors:  Ying Fang; Qianqian Yang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.